European VC Funds

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.

AI Seed is a London-based venture capital firm that focuses on early-stage investments in artificial intelligence startups. Founded in 2017, it has built a reputation as one of the UK's leading AI funds, with a portfolio exceeding 40 companies. Notable investments include Odin Vision, Rahko, and Facesoft. AI Seed supports startups primarily in sectors such as healthcare, finance, and business software, aiming to invest in innovative AI applications with the potential for significant market disruption. The fund typically invests around £100,000 in each startup, seeking 5-10% equity and often leading the seed round. It also provides extensive mentorship and support, leveraging its network to help startups access AI talent, commercial partners, and growth opportunities. AI Seed’s leadership team, including Michael Axelgaard, Jacques de Cock, and Steve Weis, brings a wealth of experience from previous successful ventures, combining technical expertise with operational know-how. While primarily active in the UK, the fund maintains connections in Silicon Valley, offering startups valuable international exposure. AI Seed’s approach emphasizes hands-on involvement, from initial funding through to scaling, with a clear strategy to prepare startups for follow-on funding and growth. The fund’s emphasis on AI-specific solutions makes it a valuable partner for founders looking to innovate within this space.

African Infrastructure Investment Managers (AIIM) is a prominent private equity firm that focuses on investing in critical infrastructure projects across Sub-Saharan and North Africa. Established in 2000, AIIM is a wholly-owned subsidiary of Old Mutual Alternative Investments, one of Africa’s leading investment groups. The firm’s headquarters is in Cape Town, South Africa, with additional offices in Nigeria, Kenya, and Côte d'Ivoire, allowing it to have a deep understanding of the diverse African business environment. AIIM manages assets valued at approximately USD 2.8 billion and has a robust portfolio of over 74 infrastructure projects spanning various sectors, including energy, transport, telecommunications, and water. The firm’s investment philosophy is centered on long-term value creation, targeting projects that not only offer substantial financial returns but also contribute to the economic development and sustainability of the regions they serve. AIIM's track record includes managing several highly successful funds, such as the African Infrastructure Investment Fund (AIIF) series, which has been instrumental in financing large-scale infrastructure projects across the continent. These funds focus on sectors that are critical to Africa's growth, including renewable energy, where AIIM has made significant investments to help transition the continent to more sustainable energy sources. With a team of 44 investment professionals, AIIM brings extensive experience and sector-specific knowledge, ensuring that their investments are managed with the highest level of expertise. AIIM continues to play a vital role in driving Africa’s infrastructure development, helping to unlock economic potential and improve the quality of life for millions across the continent.

Air Liquide, a global leader in gases, technologies, and services for industry and healthcare, is deeply committed to advancing sustainability and innovation through its strategic plan, ADVANCE. This strategy, designed for 2025, integrates financial performance with sustainable development goals, focusing heavily on decarbonization and the growth of key future markets, such as hydrogen and electronics. The company plans to reduce its CO₂ emissions by one-third by 2035 and aims for carbon neutrality by 2050. To achieve these goals, Air Liquide is investing significantly, with approximately 50% of its industrial investments allocated to the energy transition, including hydrogen technologies. The company is also simplifying its organizational structure to enhance agility and performance, enabling quicker decision-making and better customer service. Air Liquide’s efforts in decarbonization are demonstrated by projects like the large-scale Cryocap™ CO₂ capture unit in Rotterdam and the development of a global hydrogen distribution network through partnerships like TEAL Mobility with TotalEnergies. With over 66,000 employees across 60 countries, Air Liquide continues to drive forward with its dual focus on growth and sustainability, positioning itself as a leader in the transition to a low-carbon economy​.

Air Street Capital is a leading venture capital firm focused on AI-first companies, headquartered in London. Founded by Nathan Benaich, the fund aims to back innovative startups leveraging artificial intelligence across various sectors, including life sciences, enterprise software, and consumer technology. The firm has made significant investments in notable companies such as Exscientia, a pharmaceutical company listed on NASDAQ; Graphcore, an AI semiconductors company acquired by SoftBank; and Intenseye, a workplace safety platform utilizing computer vision. Other prominent investments include Recursion, ZOE, and Stability AI. Air Street Capital's investment strategy involves early-stage funding, actively iterating on product and market strategies from day one. The fund's typical investment size ranges from seed to Series A rounds, ensuring substantial support for startups at their most critical stages of development. The firm emphasizes creating enduring companies with lasting market impact, guided by a rigorous, science-driven approach to investment. The team at Air Street Capital includes experts like Alex Chalmers and Paula Pastor, who bring extensive experience in legal, operations, and platform development. Their collective expertise and strategic insights help portfolio companies navigate complex challenges and scale effectively. With a robust portfolio and a clear focus on AI-driven innovation, Air Street Capital stands out as a pivotal player in the venture capital landscape, driving forward the capabilities and applications of artificial intelligence across industries​.

Airbridge Equity Partners is an Amsterdam-based venture capital firm founded in 2017, focusing on early-stage and growth-stage investments in technology-driven companies across Europe. The firm targets scalable ventures in both B2B and B2C sectors, particularly within the digital landscape. Airbridge is known for its flexible approach, offering equity investments, follow-on expansion capital, and venture debt, allowing them to support companies throughout their growth journey. In 2023, Airbridge closed its second fund, AEP-II, with a commitment of €63 million, marking a significant step in expanding its influence in the European tech ecosystem. The fund is distinguished by its inclusion of external Limited Partners (LPs) for the first time, some of whom are founders of companies that Airbridge previously backed. This reflects strong confidence in the firm’s strategic vision and investment expertise. Airbridge’s portfolio includes notable companies like Smartlook, Roam.ai, and Honey Sales. The firm's investment strategy is centered on building deep partnerships with ambitious management teams, leveraging their extensive sector knowledge to drive growth and innovation in the tech space.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

AlbionVC, founded in 1996 and based in London, is a leading venture capital firm that focuses on early-stage investments in B2B software, healthcare, and deep tech companies primarily in the UK. The firm manages around £1 billion in venture funds and supports companies from seed to Series B stages. Notable investments in AlbionVC's portfolio include Quantexa, a data and analytics company specializing in contextual decision intelligence; Oviva, which provides app-guided programs for changing dietary and lifestyle habits; and Phrasee, a brand language optimization solution. The firm has also seen successful exits, such as Orchard Therapeutics, which focuses on gene therapies for life-threatening diseases, and Egress Software, a provider of data security solutions. AlbionVC is known for its hands-on approach, providing long-term capital and expertise to help visionary founders scale their businesses. The firm's investment strategy is characterized by its deep sector knowledge and a strong focus on innovation and growth.

BioCity is a leading life sciences incubator and early-stage investor, renowned for its focus on nurturing innovative ventures within the UK’s vibrant biotech ecosystem. With hubs across Nottingham, Alderley Park, and Scotland, BioCity supports a wide array of startups, especially those pioneering breakthroughs in biotechnology, medical devices, and drug discovery. The fund typically invests between £50,000 to £250,000, targeting companies at the seed stage, often co-investing alongside industry giants like AstraZeneca and prominent angel investors. Notable investments include Maxwellia, a pioneer in converting prescription drugs to over-the-counter solutions, and NanoSyrinx, which is developing precision therapeutics. BioCity's strategic approach is sector-agnostic within life sciences, providing not just capital but also high-end laboratory space, business support, and access to a network of industry experts. The team is led by seasoned professionals, including Dr. Imelda Juniarsih, known for her keen eye in identifying high-potential early-stage ventures. While their primary geographic focus is the UK, they are open to opportunities that align with their mission of advancing life sciences innovation. Startups seeking investment are encouraged to engage early, as BioCity values deep, collaborative relationships with its portfolio companies, often built through long-term incubation and mentorship.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Alfvén & Didrikson is a Stockholm-based venture capital firm founded in 2010 by Hjalmar Didrikson and Måns Alfvén. The firm focuses on investing in fast-growing companies in Northern Europe, particularly in sectors like fintech, SaaS, software, healthcare, media, and entertainment. Their investment stages range from pre-seed to Series A. Notable investments by Alfvén & Didrikson include Trustly, Quinyx, Acast, Mentimeter, Sympa, and Airmee. These companies span various industries, from online payments and workforce management to podcast platforms and logistics​. The firm prides itself on being a long-term backer of passionate entrepreneurs and teams with international growth ambitions. They emphasize active ownership and aim to support companies in scaling and achieving significant market impact​.

LinkedIn, the world’s largest professional networking platform, has ventured into the startup and venture capital space through LinkedIn Ventures. As part of LinkedIn’s broader strategy to foster innovation, this venture capital arm invests in early-stage companies that align with LinkedIn’s mission of connecting professionals and making them more productive. LinkedIn Ventures is especially interested in startups focused on B2B technology, artificial intelligence, machine learning, and the future of work, all of which complement LinkedIn’s core business model. The venture arm aims to support innovative startups that can help accelerate LinkedIn’s long-term goals of expanding its product ecosystem and enhancing the overall user experience for its global network of professionals. By providing both capital and strategic resources, LinkedIn Ventures helps startups scale faster, offering them access to LinkedIn’s vast user base, data, and market insights. In addition to funding, LinkedIn offers its portfolio companies the opportunity to collaborate closely with its internal teams, providing mentorship, product development advice, and marketing support. This allows the startups to leverage LinkedIn’s expertise in scaling platforms and reaching professionals across the globe. The firm’s investments are often in alignment with LinkedIn’s long-term vision of shaping the future of professional networking, HR tech, and workforce solutions. LinkedIn Ventures has positioned itself as a key player in the venture capital landscape, supporting high-potential startups while reinforcing LinkedIn’s role as a leader in connecting the global workforce.

AI2 Incubator, founded by Paul Allen's Allen Institute for AI, is a Seattle-based incubator focused on launching groundbreaking AI startups. With a mission to support AI-driven innovation, AI2 Incubator provides pre-seed investments of up to $500,000, access to $1M in cloud computing credits, and AI product development resources. Startups in its portfolio span critical areas like foundation models, AI for social good, and domain-specific AI. Some of their notable alumni include companies like Lexion, WhyLabs, and WellSaid Labs, with the incubator's startups collectively raising over $220 million. AI2 Incubator emphasizes hands-on involvement, supporting founders from ideation through Series A. It also offers extensive technical guidance, customer discovery assistance, and access to a network of AI experts. Founders from diverse backgrounds—engineers, scientists, product leaders—are encouraged to apply, with the incubator prioritizing teams that are passionate about solving real-world problems through AI. The incubator is led by a team of seasoned AI professionals, including Oren Etzioni and Jacob Colker, who work closely with startups to ensure their success in building innovative products and scaling their businesses. With deep ties to the AI2 research institute, AI2 Incubator helps startups leverage cutting-edge research to build impactful, scalable products. This unique combination of early capital, expert mentorship, and technical support has made AI2 Incubator a key player in fostering the next generation of AI-first companies.

Alliance Ventures is the strategic venture capital arm of the Renault-Nissan-Mitsubishi Alliance, one of the largest automotive groups globally. Launched in 2018, the fund focuses on investing in innovative startups that are transforming the future of mobility. With headquarters in Amsterdam and offices in key innovation hubs such as Silicon Valley, Paris, Yokohama, and Tel Aviv, Alliance Ventures targets early-stage companies developing technologies related to new mobility, autonomous driving, electric vehicles (EV), energy solutions, and connected services. The fund, with an initial capital of $200 million, primarily invests in Series A and B rounds, helping startups scale through strategic collaborations within the Alliance’s vast automotive ecosystem. Notable investments include companies like WeRide (autonomous driving in China), Enevate (battery technology), and The Mobility House (smart charging and energy storage). Alliance Ventures leverages its extensive network to provide not only capital but also partnerships and market access to accelerate startup growth. Led by a seasoned team, including General Secretary Véronique Sarlat-Depotte and Partner Ryan Armbrust, the fund actively supports startups through every growth phase, from early innovation to commercial scaling, aiming to integrate cutting-edge solutions into the Renault-Nissan-Mitsubishi operations.

Allianz, a global leader in insurance and asset management, operates through two main investment arms: Allianz Global Investors and Allianz Capital Partners. Together, they manage over €2.5 trillion in assets across diverse markets. Allianz's investment strategy focuses on generating long-term value, with a commitment to sustainability. They lead in sectors like infrastructure, renewable energy, and private equity, emphasizing a "buy and hold" approach for stability. Their investments prioritize both developed markets and key emerging areas, with notable portfolios in infrastructure and private markets, such as wind and solar energy projects, which provide consistent returns. Allianz aims to reduce market volatility risks through diversification, and their sustainable investment efforts are core to their strategy, contributing to net-zero targets. With a presence in over 70 countries, Allianz targets opportunities worldwide, emphasizing sustainable and scalable growth models. Allianz Global Investors and Capital Partners work across public and private markets, helping clients meet evolving investment goals by blending traditional assets with alternatives like private equity and renewables.

Allianz X, the digital investment arm of Allianz Group, focuses on investing in digital growth companies relevant to insurance and asset management. Since its inception, Allianz X has grown its portfolio to over 25 companies with assets under management exceeding €2 billion. The firm has identified 12 unicorns within its portfolio, showcasing its strategic investment acumen. Headquartered in Munich, Allianz X supports companies primarily in the insurtech and fintech sectors, aiming to foster innovations that complement Allianz Group's core businesses. Their investment approach includes late-stage funding, helping mature companies reach their next growth milestones. Key portfolio companies include WeLab, a leading digital financial service provider in Asia, and Pie Insurance, a digital provider of workers' compensation insurance in the U.S. Allianz X has been involved in significant funding rounds, such as co-leading a $250 million Series F investment in Coalition, Inc., a cyber insurtech company, and leading funding for London-based fintech OpenGamma. Their strategy also includes facilitating collaborative partnerships within the digital ecosystem to drive innovation and growth​.

Almaz Capital is a venture capital firm founded in 2008 by Alexander Galitsky, focusing on early-stage technology startups with global market potential. With offices in Silicon Valley and Berlin, Almaz Capital bridges entrepreneurial talent from Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS) with global markets. The firm has invested in notable companies like Acumatica, Vyatta, Parallels, and EverNote. The firm targets sectors such as Internet Infrastructure, Software, Artificial Intelligence, and Internet of Things (IoT). They are known for supporting companies through various growth stages, providing not just capital but also strategic guidance, industry connections, and operational support. Almaz Capital is committed to fostering innovation and scalability in its portfolio companies. Key team members include Alexander Galitsky (Co-Founder and Managing Partner), Charles E. Ryan (General Partner), and Geoffrey Baehr (General Partner). The team brings extensive experience in global business operations and investment, helping startups achieve significant growth and market reach.

Almi Invest is Sweden's most active early-stage venture capital firm, focusing on investing in startups across various sectors, including technology, life sciences, industry, and cleantech. As part of the state-owned Almi Group, Almi Invest operates through eight regional funds and a specialized national GreenTech fund, which targets climate-smart investments that contribute to CO2 reduction. The firm has recently raised €140 million (approximately SEK 1.6 billion) for its third investment fund, which will be deployed from 2024 to 2029. This fund aims to support around 300 startups, continuing Almi's tradition of nurturing early-stage companies across Sweden. Over its history, Almi Invest has backed nearly a thousand companies, achieving over 600 successful exits. This track record has established the firm as a cornerstone of Sweden's startup ecosystem, with many portfolio companies eventually being acquired by global giants like Google, Microsoft, and Apple. Almi Invest's regional presence is critical to its strategy, ensuring that startups throughout Sweden have access to the capital and support they need to grow. The firm’s focus on sustainability and innovation aligns with Sweden’s broader goals of fostering a vibrant, future-oriented economy.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

Alpine VC targets founders who are relentless about their products and users, focusing on companies in consumer tech, prosumer software (including tools for creators and developers), and software designed for SMBs. Alpine prioritizes product-led growth (PLG) startups and seeks companies whose products directly resonate with and serve their customers effectively. With typical check sizes from $250,000 to $1 million, they invest at the seed and Series A stages, comfortable leading, co-leading, or joining larger syndicates for flexible collaboration. Alpine operates globally but is rooted in Alameda, California. They emphasize founder passion over traditional metrics like education or professional background, valuing founders who live and breathe their products and who demonstrate an unwavering commitment to the user experience. Alpine’s strategy revolves around building strong, supportive relationships with founders, aiding in everything from go-to-market strategies to operational scaling and customer engagement. The Alpine team is known for its user-centered investment approach, thinking from the perspective of the end user to drive meaningful product development. They encourage founders to pitch directly, favoring those with a clear vision, deep product insights, and a strong connection to their target market. This lean, founder-focused approach allows Alpine to spot high-potential opportunities and help guide early-stage companies through pivotal growth stages, making Alpine an ideal partner for innovative, product-driven startups seeking flexible, strategic support.

Altamira is a Warsaw-based venture capital firm focused on investing in early-stage companies that develop innovative, practical technologies in industries like pharmaceuticals, medical devices, and industrial production. The firm actively collaborates with founders, investing not just capital but also expertise and strategic resources to help them achieve breakthroughs in international markets. Altamira targets fields where new technologies can be applied in physical realities rather than virtual ones. Their investment focus covers sectors like Internet of Things (IoT), clean tech, smart buildings, and recycling. The firm’s approach is rooted in establishing strong partnerships with ambitious teams, aiming to develop solutions with significant global revenue potential. With an average round size of around $6 million, Altamira plays an active role in supporting the companies it invests in, fostering long-term growth through continuous engagement and follow-on investments.

Alter Equity, based in Paris, is a pioneering impact investment firm founded by Fanny Picard. The firm focuses on companies that provide solutions to environmental and social challenges, adhering to an ESG-driven model that prioritizes sustainable growth. Launched in 2013, Alter Equity’s investment strategy revolves around supporting European companies with a strong focus on sectors such as renewable energy, circular economy, green chemistry, education, and well-being. They typically invest between €3 million and €10 million in companies with annual revenues above €800,000 that demonstrate strong growth potential. The firm’s portfolio includes companies like Teale, a mental health platform, Beem, which provides photovoltaic kits, and Neobrain, a human resources tech company focusing on employment management and skills development. Alter Equity is particularly committed to gender diversity, with 33% of its portfolio companies led by women, one of the highest rates in French private equity. Alter Equity stands out for its measurable impact. Its portfolio companies have collectively saved 6.8 million tons of CO2 since the firm's inception, aligning with its mission to contribute to both social and environmental sustainability.

Alven, founded in 2000 by Guillaume Aubin and Charles Letourneur, is a leading venture capital firm based in Paris with a strong focus on early-stage investments. The firm recently closed its sixth fund at €350 million, the largest early-stage fund raised in France, bringing their assets under management to €2 billion. Alven specializes in backing European entrepreneurs, with notable investments in companies like Qonto, Dataiku, Algolia, Stripe, and Ankorstore. The firm’s strategy includes investing between €100k and €15 million in seed and Series A rounds, with substantial reserves for follow-on investments. Alven supports its portfolio companies with an internal People Operations team, offering advisory services, access to talent pools, and resources to help them scale. The firm emphasizes a multi-sector specialist approach, focusing on fintech, marketplaces, enterprise software, social & entertainment, and emerging sectors like crypto and climate tech. Alven has realized more than 70 exits, including the recent sales of Sqreen to Datadog, Cardiologs to Philips, and Frichti to Gorillas. They recently expanded their geographic focus by opening a London office and continue to support European founders in the US. For startups looking to engage with Alven, it's crucial to demonstrate a strong growth potential and alignment with the firm’s commitment to long-term relationships and hands-on support​.

AM Ventures is a leading venture capital firm focused on the industrial 3D printing sector, also known as additive manufacturing. Established in Germany, AM Ventures supports early-stage startups worldwide that are innovating in areas such as materials, software, hardware, and applications related to 3D printing. The firm is renowned for its deep industry expertise and extensive global network, which spans 13 countries across four continents. The firm’s investment strategy is centered on empowering entrepreneurs who are developing next-generation technologies that can address major global challenges, including climate change, medical advancements, and digital manufacturing. AM Ventures typically invests between €500,000 and €3 million, focusing on companies from the seed stage to growth phases. In 2022, AM Ventures launched a €100 million venture capital fund dedicated to furthering its commitment to industrial 3D printing. This fund is the first of its kind, emphasizing the firm’s leadership in the additive manufacturing industry and its dedication to driving sustainable innovation on a global scale. The firm partners closely with its portfolio companies, offering not just financial backing but also strategic support and industry connections to help these startups thrive.

Amadeus Capital Partners, founded by Anne Glover and Hermann Hauser in 1997, is a renowned global technology investor. The firm has backed over 190 companies and raised more than $1 billion in investment capital. They focus on AI and machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech, and insurtech. Notable investments in their portfolio include Graphcore, FiveAI, Congenica, Sprout.ai, and Seldon. Amadeus follows a multi-faceted investment strategy: providing seed, start-up, and scale-up capital for early-stage companies in the UK, primary and secondary investments in high-growth tech companies in Europe, and growth capital for tech-enabled consumer and business services in emerging markets. They typically invest in companies with exceptional IP that have the potential to become global champions. With offices in Cambridge, London, San Francisco, and Cape Town, Amadeus Capital Partners supports scaling businesses with technical insight, operational experience, and access to a global network, including mentorship and non-executive directors. Their recent £110 million Amadeus V Technology Fund highlights their commitment to deep tech investment, with significant backing from British Patient Capital. Amadeus prefers to invest in companies that demonstrate a strong team, competitive edge, and the potential for global market impact. Founders should approach them with a well-articulated market opportunity and technological innovation to capture their interest.

Amadeus Capital Partners is a prominent global venture capital firm based in London, established in 1997 by Anne Glover and Hermann Hauser. The firm has built a strong reputation for investing in high-growth technology companies across various sectors, including artificial intelligence, cybersecurity, digital health, fintech, and semiconductors. Amadeus Capital Partners focuses on different stages of investment, providing seed, early-stage, and growth capital to companies with the potential to become global leaders. They are particularly interested in businesses with innovative intellectual property (IP) and those addressing significant, underserved market needs. The firm supports its portfolio companies with both capital and strategic guidance, aiming to build companies that can expand globally. Some of the notable investments include companies like Riverlane, which focuses on quantum computing, and Graphcore, known for its AI hardware solutions. Amadeus Capital Partners has made over 340 investments and has successfully exited over 110 companies, including high-profile exits such as Lumeon and Brytlyt. The firm’s investment approach emphasizes backing great teams, fostering innovation in billion-dollar markets, and scaling businesses to achieve global impact. With a team of over 40 professionals and a strong network of co-investors, Amadeus continues to be a significant player in the venture capital landscape, driving technological advancements across various industries​.

Amavi Capital is a specialized investment firm based in Belgium, focusing on the PropTech sector across Europe. As one of the early movers in this space, Amavi Capital distinguishes itself by bridging the gap between traditional real estate industries and innovative PropTech companies. They primarily target scale-ups with proven market fit rather than startups, providing growth capital to help these companies expand. Their investments are characterized by a strong emphasis on sustainability, operational efficiencies, and technological innovation within the real estate sector. The firm typically invests between €0.5 million and €9 million per portfolio company, with a total target fund size of €60 million. They have already completed significant investments in various European countries, including companies like Shayp (Belgium), Finch Buildings (Netherlands), and Gbuilder (Finland). Amavi Capital also integrates ESG considerations into their investment decision-making process, although they do not fully adhere to all SFDR requirements due to resource constraints. Despite this, they focus on mitigating sustainability risks and influencing portfolio companies to adopt more sustainable practices.

The Amazon Industrial Innovation Fund (AIIF) is Amazon’s $1 billion venture fund focused on advancing technologies that reshape fulfillment, logistics, and supply chain sectors. Established in 2022, the fund invests in companies across various stages, from startups to established players, that bring innovative solutions to areas like warehouse automation, robotics, and artificial intelligence. AIIF's goal is to enhance Amazon’s operations, with an emphasis on employee safety, efficiency, and customer satisfaction. Under the leadership of Franziska Bossart, the fund is expanding its scope in 2024 to target additional areas such as autonomous vehicles and last-mile delivery tech. Key investments have included companies like Agility Robotics, which develops bi-pedal robots for warehouse operations, and Vimaan, specializing in computer vision for inventory management. AIIF’s investments in companies such as Modjoul, which creates wearable safety devices, highlight its commitment to fostering technologies that support workplace safety while advancing automation. AIIF aims to support high-quality companies globally, not limited to Amazon's internal needs, as it seeks broader improvements in industrial automation and supply chain management. This makes AIIF a significant player in the field of corporate venture capital, uniquely positioned to drive impactful innovations while improving Amazon’s logistics capabilities and operational safety.

Ananda Impact Ventures, established in 2009, is a leading European venture capital firm dedicated to impact investing. The firm operates primarily in the DACH region, the UK, Benelux, and Scandinavia, focusing on early-stage investments from Seed to Series A rounds. Ananda manages around €200 million in assets across multiple funds, including their latest €108 million fund launched in 2023. Ananda invests in companies that address significant social and environmental challenges, aligning their business models with the UN’s Sustainable Development Goals. Their portfolio includes companies like OroraTech, which uses satellite technology to monitor wildfires, and NatureMetrics, which provides biodiversity data solutions through eDNA technology. The firm's investment strategy is built on their unique Impact Termsheet, which ties financial success to measurable impact outcomes. This model ensures that the impact is integral to the business, fostering long-term sustainability and growth. Ananda also emphasizes diversity and founder health, supporting entrepreneurs with robust resources and a hands-on approach to partnership. Founders appreciate Ananda's supportive and mission-aligned investment approach, which combines financial backing with strategic guidance to help scale impactful innovations. The firm prides itself on its deep commitment to creating positive societal change through venture capital.

Andera Partners, established in 2001 and headquartered in Paris, is a prominent private equity firm specializing in investments in life sciences, growth capital, and buyouts. The firm has built a strong reputation for its expertise in supporting companies at various development stages, particularly within the biotech and medical technology sectors. One of Andera's flagship initiatives is the BioDiscovery fund family, which has collectively raised over €1.1 billion to date. Their latest fund, BioDiscovery 6, closed at €456 million, highlighting significant investor confidence. This fund targets innovative therapeutic products and medical technologies, investing in companies across Europe and the United States. Notable investments include companies like Evommune, Amolyt, and TargED. Andera Partners employs a hands-on approach, providing both financial and strategic support to its portfolio companies. The firm's life sciences team, comprising experienced professionals like Sofia Ioannidou, Olivier Litzka, and Gilles Nobécourt, plays a crucial role in guiding startups from the preclinical stages to commercialization. Their strategic partnerships and extensive network bolster their ability to support high-potential innovations.

Angeleno Group, founded in 2001 and based in Los Angeles, is a venture capital firm specializing in growth capital for next-generation clean energy and climate solutions companies. With a strategic focus on sectors such as renewable energy, energy storage, sustainable mobility, and carbon mitigation, Angeleno Group aims to address critical global challenges posed by climate change. The firm leverages its extensive industry experience and longstanding relationships to support high-growth, innovative businesses. Angeleno Group invests opportunistically, typically deploying between $10 million and $30 million per opportunity, and focuses on companies with proven technologies and established customer traction. Their portfolio includes a diverse array of companies such as Fictiv, Span, and Anza RE, highlighting their commitment to fostering sustainable and transformative technologies. Angeleno Group's investment strategy is deeply rooted in creating value through active engagement with portfolio companies, providing support in product development, business strategy, sales, and corporate finance. The firm's approach is sector-focused, research-driven, and designed to build a diversified and high-return portfolio.

AngeliCo Ventures is a London-based venture capital firm and investment banking boutique founded in 2008. The firm specializes in healthcare, life sciences, and technology investments, targeting seed to growth-stage companies. AngeliCo Ventures focuses on sectors including digital health, therapeutics, diagnostics, medical devices, robotics, clean energy, and alternative care. The firm is known for its integrated strategy and investment banking solutions, offering services such as capital markets, mergers and acquisitions, strategic advisory, and research. AngeliCo Ventures prides itself on its extensive experience, having completed over $1.6 billion in transactions and raising $465 million for clients. Their approach emphasizes a strong relationship with research institutes and universities, providing early insights into high-potential discoveries. This connection helps AngeliCo Ventures to identify and support promising investment opportunities, guiding companies from inception through various stages of financing and strategic development.

Angelini Ventures is the corporate venture capital arm of Angelini Industries, founded in 2021 and headquartered in Rome, Italy. With a capital commitment of €300 million, Angelini Ventures focuses on early-stage investments in biotechnology, digital health, and life sciences. The firm aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations. The firm has made significant investments globally, including in Europe, North America, and Israel, with a particular emphasis on brain health and consumer segments such as women, children, and the elderly. Notable portfolio companies include Pretzel Therapeutics, Argobio, Serenis, and Nouscom. Angelini Ventures is led by CEO Paolo Di Giorgio, who has extensive experience in the pharmaceutical and investment sectors. The team includes experts such as Elia Stupka, Managing Director, and Gabriela Manrique, Partner, among others, spread across major innovation hubs globally​.

Angelize is a Berlin-based platform designed for experienced founders across Europe to engage in angel investing. Its mission is to enable successful entrepreneurs to give back to the startup community by investing in the next generation of founders. By fostering a collaborative environment, Angelize helps these "founder-angels" remain active and relevant in the tech ecosystem. The platform simplifies the investment process by providing back-office support, making it easier for founders to focus on mentoring and guiding emerging startups. The program targets founders who have "earned their wings" and are looking for ways to support and mentor other entrepreneurs. Through Angelize, they gain access to a network of like-minded peers and promising startups, creating valuable opportunities for learning, growth, and meaningful impact. With a strong focus on fostering connections across the European tech landscape, Angelize is not just about financial investment but about building long-term relationships between seasoned founders and up-and-coming companies. Angelize stands out by combining financial backing with hands-on mentorship, ensuring that startups not only receive capital but also benefit from the extensive experience and insights of their investors. By bridging the gap between successful founders and new startups, Angelize plays a crucial role in supporting the entrepreneurial ecosystem across Europe.

Angels Santé, established in 2008 and based in Paris, is the largest healthcare-focused business angel network in Europe. It supports early-stage startups in the Biotech, Medtech, and Digital Health sectors, helping bring innovative solutions to market that benefit patients. With over 100 investments made since its inception, the organization fosters partnerships between entrepreneurs and healthcare professionals, providing not only capital but also deep industry expertise in clinical, regulatory, and scientific domains. Each year, Angels Santé finances 10-15 deals, with a focus on Europe, but its reach extends globally through partnerships with organizations like EBAN and Business Angels Europe. This international collaboration allows Angels Santé to facilitate cross-border investments and provide startups with access to a broader market. The network emphasizes a hands-on approach, guiding startups through the complexities of the healthcare landscape by offering mentorship and connections to relevant stakeholders. Notable figures such as Eric Garnier, the president, emphasize the critical role that healthcare innovation plays in solving modern challenges. Furthermore, their US branch, based in Boston, extends opportunities for French-speaking investors in the United States to support healthcare startups with global aspirations. Angels Santé is not just about funding; it's about building a community dedicated to advancing healthcare through innovation, with a long-term commitment to improving patient outcomes and supporting the growth of impactful healthcare companies.

Anglo Scientific is a venture capital firm that provides management and back-office services to high-tech startups, with a particular focus on artificial intelligence projects since its restructuring in November 2020. The firm, headquartered at The Elms Courtyard in Bromesberrow, UK, assists startups with essential administrative tasks such as payroll, accounts, HR, tax returns, and more, allowing entrepreneurs to focus on innovation and growth. Anglo Scientific has a comprehensive approach to supporting startups, managing tasks that often consume significant time for new businesses. Their portfolio includes companies that benefit from these streamlined services, enabling them to navigate the complexities of early-stage growth and investment readiness​.

Angular Ventures, founded in 2018 and headquartered in London with offices in Tel Aviv and New York, focuses on early-stage enterprise tech companies from Europe and Israel. The firm invests in deep tech sectors including AI, machine learning, developer tools, fintech, and infrastructure. They are known for backing companies with global ambitions and exceptional founding teams. Their portfolio includes companies like JFrog, a developer-focused software company that went public in 2020, and Forter, which provides e-commerce fraud prevention solutions. Aquant, another notable investment, uses AI to provide actionable service intelligence and was acquired by SmartBear. Dust Identity, which utilizes diamond dust for product authentication, recently raised a $40M Series B to expand into new markets. Reco focuses on business and productivity software, emphasizing data security and collaboration. Angular Ventures recently announced a $41M seed fund aimed at supporting enterprise and deep tech startups in Europe and Israel. This fund underscores their commitment to fostering innovation in these regions and sectors, ensuring that promising startups receive the necessary support to scale and succeed globally​.

ANIM is a global venture capital fund with a strong focus on investing in high-growth, innovative companies across various sectors. Based on available information, ANIM targets industries that leverage cutting-edge technologies, though specific sectors or portfolio companies were not clearly outlined. The fund appears to be driven by a mission to back transformative ventures that can scale rapidly, with a global perspective on markets and opportunities. ANIM's strategy seems to include early-stage investments, providing capital and strategic guidance to help startups grow. The fund likely looks for companies with strong leadership, scalability, and market potential. With its emphasis on growth, it’s reasonable to assume that ANIM plays an active role in the businesses it backs, offering more than just financial support. For entrepreneurs seeking investment, the fund might prioritize innovative solutions that have the potential for significant impact, both financially and in terms of market disruption.

Anorak Ventures, founded in 2016 and headquartered in San Francisco, is a seed-stage venture firm that focuses on investing in transformative technology and people. The firm primarily invests in pre-seed and seed-stage companies across various technology sectors, including artificial intelligence and machine learning (AI/ML), Internet of Things (IoT), robotics, and consumer tech. Anorak Ventures has invested in over 120 seed-stage technology companies, which now represent an aggregate market capitalization of $24.8 billion. Notable investments in their portfolio include companies such as Vantage Point, WeatherCheck, Orderful, Framework, Prisms VR, Better Health, and Marxent. They are dedicated to helping these companies achieve product-market fit and secure follow-on financing. The firm, led by Managing Partner Greg Castle, aims to support innovative startups by providing not just capital but also strategic guidance to help them scale and succeed in competitive markets​.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Anthemis Group, founded in 2010 and headquartered in London, is a global investment platform dedicated to fostering innovation in the financial system. The firm focuses on fintech, insurtech, and related sectors, investing from seed to growth stages. Anthemis' portfolio includes notable companies such as Betterment, eToro, and Currencycloud. They also back innovative startups like Pipe, Weavr, and Atomic. With over 150 investments worldwide, Anthemis emphasizes diversity and inclusivity, with 23% of their portfolio companies founded by women and 40% led by women or BIPOC. Their commitment to diversity is further demonstrated through the Female Innovators Lab, which supports female founders in fintech across the UK and Europe. Anthemis recently closed multiple funds totaling over $700 million, expanding their support for fintech companies throughout their lifecycle. The firm also launched an ESG-focused SPAC to advance sustainable finance. Anthemis' thesis-driven approach leverages deep market insights to drive systemic, long-term change. Led by founder Amy Nauiokas and CEO Briana van Strijp, Anthemis is poised to continue its mission of reinventing finance through innovation, collaboration, and inclusivity, supporting the next wave of fintech innovation globally.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Apollo Health Ventures is a transatlantic venture capital firm with offices in Berlin and Boston, focusing on biotechnology and health tech ventures aimed at extending human healthspan. Established in 2016, Apollo specializes in seed and early-stage investments, particularly in companies that target aging-related diseases and conditions. Their investments focus on developing technologies and therapeutics that address the root causes of aging, helping to maintain cellular health, reduce chronic inflammation, and strengthen the immune system. In 2021, Apollo closed its second fund at $180 million, supported by both existing and new investors. This fund is designed to build and invest in data-driven companies developing breakthrough treatments for age-related diseases. Apollo has co-founded several pioneering companies, including Samsara Therapeutics, which develops autophagy-enhancing molecules, and Aeovian Pharmaceuticals, which focuses on therapeutics to extend healthspan. The firm is led by a team of experienced biotech investors and entrepreneurs, including co-founder Nils Regge, whose ventures have raised over $1 billion in capital. The team also includes Dr. Jens Eckstein, a seasoned venture capitalist with a history of successful biotech investments, and Dr. Marianne Mertens, who brings extensive experience from life sciences and venture investing. With its unique focus on longevity and aging-related innovation, Apollo Health Ventures is at the forefront of biotech ventures aiming to transform healthcare.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Apposite Capital is a London-based venture capital firm specializing in the healthcare sector. Founded in 2006, the firm focuses on investing in innovative healthcare companies across the UK and Europe. Apposite Capital provides a mix of venture, development, and growth financing, along with buyout capital, primarily targeting companies that can significantly impact healthcare through improved services and technologies. Their investment strategy emphasizes supporting companies with scalable business models and strong growth potential. Apposite Capital has a track record of successful investments in healthcare services, medical devices, diagnostics, and digital health. The firm typically takes an active role in its portfolio companies, providing strategic guidance and leveraging its extensive network within the healthcare industry to drive growth and innovation. Apposite Capital's team brings a combination of operational, scientific, and financial expertise, allowing them to deeply understand and support the unique needs of healthcare businesses. They also focus on promoting best practices in environmental, social, and governance (ESG) and are committed to making a positive impact through their investments. Recent notable investments include companies like NIMGenetics, HCML, and Emblation, showcasing their commitment to advancing healthcare solutions and improving patient outcomes​.

Aqua-Spark, based in the Netherlands, is a global investment fund dedicated to sustainable aquaculture. Founded in 2013 by Mike Velings and Amy Novogratz, the fund aims to transform the aquaculture industry by promoting environmental and social sustainability alongside financial returns. Aqua-Spark's mission is to make the production of aquatic life such as fish, shellfish, and plants safe, accessible, and environmentally friendly. The fund manages around $450 million in assets and has invested in 24 companies across the aquaculture value chain, aiming to expand its portfolio to 50-60 companies. Some notable investments include eFishery, an Indonesian aquaculture tech startup, Calysta, a biotech company producing sustainable feed ingredients, and Wanda Fish, which is developing cultivated bluefin tuna. Aqua-Spark focuses on early-stage investments, typically at the Series A stage, and supports companies through to maturity. Their investments are chosen for their potential to generate significant environmental and social impacts while delivering solid financial returns. The fund has a diverse investor base of around 300 investors from over 25 countries.